Operational Guidance (D4.4)

Christine Radawski; Kristin Bullok; Carl Steinbeisser; Quazi Ataher; Jorien Veldwijk; Monika Borchert; Carol Mansfield; Emuella Flood; Susan Bhatti; Laurent Ecochard; Isabelle Naeije; Vicky Hawkins; Anja Becher; Rowan Pierce; Isabelle Huys; Irina Cleemput; Mireille Muller; Carmit Strauss; Josepine Fernow

doi:10.5281/zenodo.6421743

Published March 31, 2022 | Version v3

Other Open

Operational Guidance (D4.4)

1. Eli Lilly
2. Steinbeißer Project Management
3. CSL Behring
4. Erasmus University of Rotterdam
5. Novartis
6. RTI
7. AstraZeneca
8. Merck KGaA
9. Pharmagenesis
10. KU Leuven
11. KCE
12. Amgen
13. Uppsala University

Along with the PREFER Recommendations, PREFER has developed operational guidance and training material to further assist in a patient preference study. The operational guidance consists of templates to utilize in the development and execution of a patient preference study.

Files

PREFER_Deliverable_4.4_Operational Guidance.pdf

Files (484.0 kB)

Name	Size	Download all
PREFER_Deliverable_4.4_Operational Guidance.pdf md5:c5b6c6701bab8ec39d4e655719c422cc	161.3 kB	Preview Download
PREFER_Deliverable_4.4_Operational_Guidance 3.pdf md5:5f01e643faa55d766553216608c3f227	161.4 kB	Preview Download
PREFER_Deliverable_4.4_Operational_Guidance.pdf md5:ff44ed39edcc52ef867b7cf098b70b26	161.3 kB	Preview Download

Additional details

European Commission
PREFER – Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 115966

	All versions	This version
Views	803	42
Downloads	390	25
Data volume	77.6 MB	6.5 MB

Operational Guidance (D4.4)

Creators

Description

Files

PREFER_Deliverable_4.4_Operational Guidance.pdf

Files (484.0 kB)

Additional details

Funding